Current Treatment Options in Gastroenterology

, Volume 6, Issue 5, pp 369–374 | Cite as

Pancreatic enzyme supplementation therapy

  • Jutta Keller
  • Peter Layer

Opinion statement

Effective treatment of malabsorption due to severe pancreatic exocrine insufficiency requires delivery of sufficient enzymatic activity into the duodenal lumen simultaneously with meal nutrients. To achieve this, modern therapeutic concepts recommend administration of 25,000 to 40,000 units of lipase per meal using pH-sensitive pancreatin microspheres. In case of treatment failure, dosage should be increased two to three times. If this still is not successful, compliance may be checked by measurement of fecal chymotrypsin, although this is not a standardized procedure. In the compliant patient, diagnosis of pancreatic exocrine insufficiency needs to be reviewed, particularly cases of celiac disease, (concomitant) bacterial overgrowth, and blind loop syndrome, as well as giardiasis, which need to be excluded or otherwise be treated specifically. Finally, additional acid suppression with application of unprotected pancreatin and/or reduced fat intake may help to control malabsorption. Still, in most patients, lipid digestion cannot be completely normalized by current standard therapy. On the one hand, this leads to loss of energy that may only partly be compensated for by increased nutrient intake. On the other hand, increased nutrient exposition of distal intestinal sites may release excessive amounts of mostly inhibitory distal intestinal neurohumoral mediators, and thereby disturb gastrointestinal secretory and motor functions. Consequently, future developments are needed for optimizing treatment.


Lipase Chronic Pancreatitis Celiac Disease Pancreatic Enzyme Pancreatic Insufficiency 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Layer P, Yamamoto H, Kalthoff L, et al.: The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology 1994, 107:1481–1487.PubMedGoogle Scholar
  2. 2.
    Maton PN, Selden AC, Fitzpatrick ML, Chadwick VS: Defective gallbladder emptying and cholecystokinin release in celiac disease. Reversal by gluten-free diet. Gastroenterology 1985, 88:391–396.PubMedGoogle Scholar
  3. 3.
    DiMagno EP, Go WL, Summerskill WH: Impaired cholecystokinin-pancreozymin secretion, intraluminal dilution, and maldigestion of fat in sprue. Gastroenterology 1972, 63:25–32.PubMedGoogle Scholar
  4. 4.
    Keller J, Melle U, Hoene K, et al.: Decreased digestive stimulation of pancreatic enzyme secretion in Crohńs disease [abstract]. Pancreas 2000, 21:453.Google Scholar
  5. 5.
    Degen LP, Beglinger C: Postoperative gastrointestinal physiology following operations on the stomach. Pancreatology 2001, 1:9–13. Review focuses on postoperative pancreatic exocrine function, indications, and recommendations for enzyme treatment and their basis of evidence.CrossRefGoogle Scholar
  6. 6.
    Friess H, Tempia-Caliera AA, Büchler MW: Indication for pancreatic enzyme substitution following gastric resection. Pancreatology 2001, 1:41–48. Review focuses on postoperative pancreatic exocrine function, indications, and recommendations for enzyme treatment and their basis of evidence.CrossRefGoogle Scholar
  7. 7.
    Layer P, Melle U: Indication for pancreatic enzyme substitution following small intestinal resection (short bowel syndrome). Pancreatology 2001, 1(suppl 1):49–54. Review focuses on postoperative pancreatic exocrine function, indications, and recommendations for enzyme treatment and their basis of evidence.CrossRefGoogle Scholar
  8. 8.
    DiMagno EP, Go VL, Summerskill WH: Relations between pancreatic enzyme ouputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 1973, 288:813–815.PubMedCrossRefGoogle Scholar
  9. 9.
    Layer P, Ohe M, Groeger G, Dicke D, Goebell H: Luminal availability and digestive efficacy of substituted enzymes in pancreatic insufficiency [abstract]. Pancreas 1992, 7:45.CrossRefGoogle Scholar
  10. 10.
    Keller J, Runzi M, Goebell H, Layer P: Duodenal and ileal nutrient deliveries regulate human intestinal motor and pancreatic responses to a meal. Am J Physiol 1997, 272:G632-G637.PubMedGoogle Scholar
  11. 11.
    Layer P, Peschel S, Schlesinger T, Goebell H: Human pancreatic secretion and intestinal motility: effects of ileal nutrient perfusion. Am J Physiol 1990, 258:G196-G201.PubMedGoogle Scholar
  12. 12.
    Read NW, McFarlane A, Kinsman RI, et al.: Effect of infusion of nutrient solutions into the ileum on gastrointestinal transit and plasma levels of neurotensin and enteroglucagon. Gastroenterology 1984, 86:274–280.PubMedGoogle Scholar
  13. 13.
    Layer P, von Der O, Holst JJ, et al.: Altered postprandial motility in chronic pancreatitis: role of malabsorption. Gastroenterology 1997, 112:1624–1634.PubMedCrossRefGoogle Scholar
  14. 14.
    Slaff J, Jacobson D, Tillman CR, et al.: Protease-specific suppression of pancreatic exocrine secretion. Gastroenterology 1984, 87:44–52.PubMedGoogle Scholar
  15. 15.
    Gullo L, Barbara L, Labo G: Effect of cessation of alcohol use on the course of pancreatic dysfunction in alcoholic pancreatitis. Gastroenterology 1988, 95:1063–1068.PubMedGoogle Scholar
  16. 16.
    DiMagno EP, Clain JE, Layer P: Chronic pancreatitis In The Pancreas: Biology, Pathobiology and Disease, edn 2. Edited by Go VL. New York: Raven Press; 1993:665–706.Google Scholar
  17. 17.
    Suzuki A, Mizumoto A, Rerknimitr R, et al.: Effect of bacterial or porcine lipase with low-or high-fat diets on nutrient absorption in pancreatic-insufficient dogs. Gastroenterology 1999, 116:431–437.PubMedCrossRefGoogle Scholar
  18. 18.
    Caliari S, Benini L, Sembenini C, et al.: Medium-chain triglyceride absorption in patients with pancreatic insufficiency. Scand J Gastroenterol 1996, 31:90–94.PubMedGoogle Scholar
  19. 19.
    Layer P, Keller J, Lankisch A: Pancreatic enzyme replacement therapy. Curr Gastroenterol Rep 2001, 3:101–108.PubMedCrossRefGoogle Scholar
  20. 20.
    Casellas F, Guarner L, Vaquero E, et al.: Hydrogen breath test with glucose in exocrine pancreatic insufficiency. Pancreas 1998, 16:481–486.PubMedCrossRefGoogle Scholar
  21. 21.
    Regan PT, Malagelada JR, DiMagno EP, Go VL: Rationale for the use of cimetidine in pancreatic insufficiency. Mayo Clin Proc 1978, 53:79–83.PubMedGoogle Scholar
  22. 22.
    Heijerman HG, Lamers CB, Bakker W: Omeprazole enhances the efficacy of pancreatin (pancrease) in cystic fibrosis. Ann Intern Med 1991, 114:200–201.PubMedGoogle Scholar
  23. 23.
    DiMagno EP, Malagelada JR, Go VL, Moertel CG: Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules. N Engl J Med 1977, 296:1318–1322.PubMedCrossRefGoogle Scholar
  24. 24.
    Kolbel C, Layer P, Hotz J, Goebell H: Effect of an acid protected, micro-encapsulated pancreatin preparation on pancreatogenic steatorrhea. Med Klin 1986, 81:85–86.Google Scholar
  25. 25.
    Schneider MU, Knoll-Ruzicka ML, Domschke S, et al.: Pancreatic enzyme replacement therapy: comparative effects of conventional and enteric-coated microspheric pancreatin and acid-stable fungal enzyme preparations on steatorrhoea in chronic pancreatitis. Hepatogastroenterology 1985, 32:97–102.PubMedGoogle Scholar
  26. 26.
    Moreau J, Bouisson M, Saint MG, et al.: Comparison of fungal lipase and pancreatic lipase in exocrine pancreatic insufficiency in man. Study of their in vitro properties and intraduodenal bioavailability. Gastroenterol Clin Biol 1988, 12:787–792.PubMedGoogle Scholar
  27. 27.
    FitzSimmons SC, Burkhart GA, Borowitz D, et al.: Highdose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med 1997, 336:1283–1289.PubMedCrossRefGoogle Scholar
  28. 28.
    Mac SE, Oades PJ, Buchdahl R, et al.: Relation of thickening of colon wall to pancreatic-enzyme treatment in cystic fibrosis. Lancet 1995, 345:752–756.CrossRefGoogle Scholar
  29. 29.
    Smyth RL, Ashby D, O’Hea U, et al.: Fibrosing colonopathy in cystic fibrosis: results of a case-control study. Lancet 1995, 346:1247–1251.PubMedCrossRefGoogle Scholar
  30. 30.
    Prescott P, Bakowski MT: Pathogenesis of fibrosing colonopathy: the role of methacrylic acid copolymer. Pharmacoepidemiol Drug Safety 1999, 8:377–384.CrossRefGoogle Scholar
  31. 31.
    Dunger DB, Burns C, Ghale GK, et al.: Pancreatic exocrine and endocrine function after subtotal pancreatectomy for nesidioblastosis. J Pediatr Surg 1988, 23:112–115.PubMedCrossRefGoogle Scholar
  32. 32.
    Kodama M, Tanaka T: Residual function of exocrine pancreas after operation for chronic pancreatitis by Nbenzoyl-L-tyrosyl-p-aminobenzoic acid test (NBTPABA test). Digestion 1984, 30:41–46.PubMedCrossRefGoogle Scholar
  33. 33.
    Suzuki A, Mizumoto A, Sarr MG, DiMagno EP: Bacterial lipase and high-fat diets in canine exocrine pancreatic insufficiency: a new therapy of steatorrhea? Gastroenterology 1997, 112:2048–2055.PubMedCrossRefGoogle Scholar
  34. 34.
    Kuhel DG, Zheng S, Tso P, Hui DY: Adenovirus-mediated human pancreatic lipase gene transfer to rat bile: gene therapy of fat malabsorption. Am J Physiol Gastrointest Liver Physiol 2000, 279:G1031-G1036. Pivotal experimental study suggesting that ectopic expression of pancreatic enzymes in the hepatobiliary tract may be an alternative therapeutic strategy for treating fat malabsorption due to pancreatic insufficiencyPubMedGoogle Scholar
  35. 35.
    Maeda H, Danel C, Crystal RG: Adenovirus-mediated transfer of human lipase complementary DNA to the gallbladder. Gastroenterology 1994, 106:1638–1644.PubMedGoogle Scholar
  36. 36.
    Layer P, Keller J: Pancreatic enzymes: secretion and luminal nutrient digestion in health and disease. J Clin Gastroenterol 1999, 28:3–10.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2003

Authors and Affiliations

  • Jutta Keller
    • 1
  • Peter Layer
    • 1
  1. 1.Department of MedicineIsraelitic HospitalHamburgGermany

Personalised recommendations